Moneycontrol
HomeNewsBusinessOver a year ago, he nearly quit. Now, thanks to COVID-19, entrepreneur Rajeev Karwal has got a fresh breath of life
Trending Topics

Over a year ago, he nearly quit. Now, thanks to COVID-19, entrepreneur Rajeev Karwal has got a fresh breath of life

From a drastic fall in revenues in 2019, Karwal's Milagrow has recorded a 723 percent growth in revenues in the second quarter.

November 11, 2020 / 15:20 IST
Story continues below Advertisement

Hundreds of companies in India were forced to shut down because of COVID-19. By one estimate, done by FICCI, 12 percent of start-ups alone closed down during the past eight months. The impact on the rest of the MSMEs is similar.

But Rajeev Karwal is one of the few entrepreneurs who found a saviour in the pandemic. "In the last quarter, our revenue grew by 723 percent, year-on-year. For the full year, we expect revenues to jump five times," says the founder of Milagrow Humantech.

Story continues below Advertisement

How did the spectacular turnaround happen? Not just for the company, but also for Karwal, who just a little over a year ago, was thinking of quitting?

A quick rewind.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show